Obtain baseline serum calcium, parathyroid hormone (PTH), and creatinine levels. Confirm ultrasound localization of the hyperfunctioning parathyroid adenoma. Ensure the patient has ceased antiplatelet or anticoagulant medications for 5 days. Verify informed consent. No fasting is required as the procedure is performed under local anesthesia.
Patient to remain in a seated position for 30 minutes post-procedure for observation of neck swelling or pain. Apply a cold compress to the site to reduce localized inflammation. Patient may resume normal activity immediately. Instruct the patient to monitor for signs of recurrent laryngeal nerve injury (hoarseness) or hematoma and report to the clinic if symptoms arise. Follow-up blood tests for calcium and PTH scheduled at 1 week and 1 month.
Comprehensive Clinical Guide: Percutaneous Parathyroid Ethanol Injection (PEIT)
Percutaneous Parathyroid Ethanol Injection (PEIT) represents a minimally invasive, image-guided therapeutic intervention designed to treat hyperfunctioning parathyroid glands. Primarily utilized in cases of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), or as a salvage therapy for primary hyperparathyroidism (PHPT) in patients who are poor surgical candidates, PEIT has evolved into a cornerstone of interventional endocrinology.
This guide provides an exhaustive clinical overview of the procedure, its indications, technical execution, and management protocols.
1. Overview and Mechanism of Action
The Biological Basis of Ethanol Ablation
The fundamental mechanism of PEIT is chemical neurolysis and dehydration. When absolute ethanol (typically 95-99% concentration) is injected into the parenchyma of a hyperplastic or adenomatous parathyroid gland, it induces rapid cellular dehydration and protein denaturation.
- Coagulative Necrosis: The ethanol causes immediate intracellular dehydration, leading to the precipitation of cytoplasmic proteins.
- Vascular Thrombosis: The injection induces thrombosis within the small vessels supplying the gland, resulting in ischemic necrosis.
- Fibrosis: Over the weeks following the procedure, the necrotic tissue is replaced by fibrous scar tissue, effectively rendering the gland non-functional and reducing the secretion of Parathyroid Hormone (PTH).
2. Clinical Indications and Patient Selection
PEIT is not a first-line treatment for all parathyroid pathologies. It is specifically indicated for patients where conventional parathyroidectomy is deemed high-risk or technically unfeasible.
Primary Indications
- Secondary Hyperparathyroidism (SHPT): Patients with end-stage renal disease (ESRD) exhibiting severe hypercalcemia or elevated PTH levels that are refractory to medical management (calcimimetics, phosphate binders).
- Surgical Contraindications: Patients with severe cardiovascular comorbidities, previous neck surgeries (with high risk of recurrent laryngeal nerve injury), or anatomical barriers.
- Recurrent/Persistent Hyperparathyroidism: Cases where previous surgical neck exploration failed to identify or remove the hyperfunctioning gland.
Contraindications
- Relative: Coagulopathy (must be corrected prior to intervention), proximity to the recurrent laryngeal nerve, or retrosternal parathyroid location (inaccessible via ultrasound).
- Absolute: Severe cervical anatomical distortion, suspected parathyroid carcinoma (where biopsy/rupture could lead to seeding), or patient inability to remain still during the procedure.
3. Pre-Operative Preparation
Success in PEIT is highly dependent on meticulous pre-procedural imaging and laboratory workup.
Diagnostic Workup Table
| Parameter | Importance |
|---|---|
| Ultrasound (US) | Essential for localization, size measurement, and vascular mapping. |
| Sestamibi Scan | Confirms the metabolic hyperactivity of the target gland. |
| Serum PTH | Baseline measurement for post-procedural comparison. |
| Coagulation Profile | PT/INR and Platelet count (must be within normal limits). |
Patient Preparation
- Fast: NPO for 4–6 hours prior to the procedure.
- Sedation: Conscious sedation is typically employed.
- Positioning: Patient is placed supine with the neck extended using a pillow under the shoulders to optimize the surgical field.
4. The Procedure: Step-by-Step Technical Execution
PEIT is performed under ultrasound guidance, typically by an interventional radiologist or an endocrine surgeon trained in ultrasound-guided interventions.
Step 1: Localization and Sterilization
The target gland is identified using high-frequency ultrasound. The neck is prepped and draped in a sterile fashion. Local anesthesia (lidocaine 1%) is injected into the skin and subcutaneous tissues along the anticipated needle track.
Step 2: Needle Insertion
A fine-gauge needle (22G to 25G) is inserted under real-time ultrasound guidance. The tip is positioned within the central portion of the parathyroid gland.
Step 3: Ethanol Administration
- Volume: The volume of ethanol injected is usually determined by the volume of the gland (the "Rule of Thumb" is roughly 50–100% of the gland volume, though caution is required to avoid leakage).
- Technique: Ethanol is injected slowly. The operator monitors for "hyperechoic blurring" on the ultrasound, which indicates the diffusion of ethanol into the gland parenchyma.
- Leakage Prevention: If the needle is near the thyroid capsule or carotid sheath, extreme caution is taken to prevent extracapsular leakage.
Step 4: Withdrawal
Once the injection is complete, the needle is withdrawn slowly while applying pressure to the tract to prevent hematoma formation and minimize the risk of ethanol tracking back into the soft tissues.
5. Post-Operative Recovery and Monitoring
Recovery from PEIT is generally rapid, with most patients discharged within 2–4 hours post-procedure.
- Immediate Monitoring: Vital signs are checked every 30 minutes for the first 2 hours.
- Pain Management: Mild neck discomfort or "burning" sensations are common and usually managed with oral acetaminophen or NSAIDs.
- Follow-up Labs: PTH levels are typically reassessed at 24 hours, 1 week, and 1 month post-procedure.
- Imaging Follow-up: Ultrasound is repeated at 3 months to assess for gland shrinkage.
6. Complications and Management
While generally safe, PEIT is an invasive procedure with potential risks.
| Complication | Mechanism | Mitigation |
|---|---|---|
| Recurrent Laryngeal Nerve (RLN) Palsy | Ethanol leakage/edema | Careful ultrasound guidance; avoid injection near the tracheoesophageal groove. |
| Hematoma | Needle injury to vessels | Manual compression post-procedure. |
| Thyrotoxicosis | Release of thyroid hormones | Rare; monitor if patient has underlying thyroid nodules. |
| Local Pain/Inflammation | Chemical irritation | Cold packs; OTC analgesics. |
7. Alternative Treatments
When PEIT is not suitable, or if it fails, clinicians must consider other modalities:
1. Parathyroidectomy: The gold standard for primary hyperparathyroidism.
2. Radiofrequency Ablation (RFA): A thermal alternative that uses heat rather than chemicals to destroy the tissue.
3. Medical Management: Use of Cinacalcet (calcimimetics) to manage PTH levels in dialysis patients.
8. Frequently Asked Questions (FAQ)
1. Is PEIT painful?
Most patients report a transient burning sensation during the injection. Local anesthesia significantly mitigates skin and subcutaneous pain.
2. How many sessions are usually required?
While some adenomas respond to a single injection, larger glands or secondary hyperparathyroidism often require 2–3 sessions.
3. What is the success rate of PEIT?
Success rates vary by condition, but generally, 70–90% of patients achieve a significant reduction in PTH levels.
4. Can PEIT be performed on pregnant patients?
It is generally avoided due to the risks of sedation and potential fetal exposure to stress, unless the hyperparathyroidism poses a life-threatening risk.
5. How long does the procedure take?
The intervention itself usually takes 15–30 minutes, excluding preparation and recovery time.
6. Will I need surgery after PEIT?
Not necessarily. Many patients achieve long-term biochemical control. However, some may eventually require surgery if the gland regrows.
7. Does the ethanol affect the thyroid gland?
If performed correctly, the thyroid gland is largely unaffected. However, minor thyroiditis can occur if ethanol leaks into the thyroid parenchyma.
8. Is there a risk of voice change?
Hoarseness can occur due to temporary inflammation near the recurrent laryngeal nerve, but permanent nerve damage is very rare when performed by an experienced specialist.
9. How soon can I return to work?
Most patients can return to normal daily activities within 24–48 hours.
10. What if the PTH levels do not drop?
If PTH levels remain unchanged after multiple sessions, it suggests the target gland was not the sole source of hyperparathyroidism, or that the ethanol failed to cause sufficient necrosis. Surgical exploration is then usually recommended.
9. Conclusion
Percutaneous Parathyroid Ethanol Injection (PEIT) stands as a vital, minimally invasive tool in the management of complex parathyroid disease. By leveraging chemical ablation, clinicians can offer a viable alternative to high-risk surgery, ensuring that even the most fragile patients can achieve biochemical stability. Future advancements in ultrasound technology and navigation will likely further refine the safety profile and efficacy of this procedure, cementing its role in modern interventional endocrinology.
Disclaimer: This guide is for educational purposes only. All medical procedures should be performed by qualified healthcare professionals in an appropriate clinical setting. Clinical decisions should be based on individual patient assessment and institutional protocols.